Get the latest tech news
Scientists from Tufts create weight-loss drug dubbed 'next Ozempic' that's twice as effective and has fewer side effects (affects not only GLP-1 and GIP, but also glucagon and peptide YY)
Scientists have created a new weight-loss drug dubbed the 'next Ozempic' that's said to be twice as effective and come with fewer side effects
"We built a single experimental peptide that works like four hormones at once, so we’re not pushing one button too hard," lead author of the Tufts study Tristan Dinsmore, PhD told Fox News Digital. Published in the Journal of the American Chemical Society, the research shows that scientists intend to rely more on GIP as it's known to help relieve nausea, which can be caused by GLP‑1 and PYY when administered in higher doses. (Getty Stock Images)"Beyond helping with fullness and glucose control, GIP signaling has anti‑nausea effects — it can even block nausea in preclinical models, which is why we prioritize it in the mix," Dinsmore continued.
Or read this on r/technology
